Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,734 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.
Araújo A, Coelho A, de Mello RA, Azevedo I, Soares M, Queiroga H, Teixeira E, Parente B, Barata F. Araújo A, et al. Among authors: soares m. Rev Port Pneumol. 2012 Sep-Oct;18(5):244-6. doi: 10.1016/j.rppneu.2012.04.011. Epub 2012 Jun 29. Rev Port Pneumol. 2012. PMID: 22748945 Free article. English, Portuguese. No abstract available.
Lung cancer in Northern Portugal: A hospital-based study.
Hespanhol V, Parente B, Araújo A, Cunha J, Fernandes A, Figueiredo MM, Neveda R, Soares M, João F, Queiroga H. Hespanhol V, et al. Among authors: soares m. Rev Port Pneumol. 2013 Nov-Dec;19(6):245-51. doi: 10.1016/j.rppneu.2013.05.005. Epub 2013 Oct 9. Rev Port Pneumol. 2013. PMID: 24119922 Free article. English, Portuguese.
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut.
Barata F, Queiroga H, Teixeira E, Almodovar MT, Parente B, Soares M. Barata F, et al. Among authors: soares m. Rev Port Pneumol (2006). 2016 Sep-Oct;22(5):287-8. doi: 10.1016/j.rppnen.2016.03.009. Epub 2016 May 6. Rev Port Pneumol (2006). 2016. PMID: 27162148 Free article. Clinical Trial. No abstract available.
Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Figueiredo A, Almeida MA, Almodovar MT, Alves P, Araújo A, Araújo D, Barata F, Barradas L, Barroso A, Brito U, Camacho E, Canário D, Cardoso T, Chaves A, Costa L, Cunha J, Duarte J, Estevinho F, Felizardo M, Fernandes JP, Ferreira L, Ferreira L, Fidalgo P, Freitas C, Garrido P, Gil N, Hasmucrai D, Jesus E, Lopes JA, de Macedo JE, Meleiro A, Neveda R, Nogueira F, Pantorotto M, Parente B, Pego A, Rocha M, Roque J, Santos C, Saraiva J, Silva E, Silva S, Simões S, Soares M, Teixeira E, Timóteo T, Hespanhol V. Figueiredo A, et al. Among authors: soares m. Pulmonology. 2020 Jan-Feb;26(1):10-17. doi: 10.1016/j.pulmoe.2019.06.001. Epub 2019 Oct 18. Pulmonology. 2020. PMID: 31630986 Free article.
3,734 results